Skip to main content
PMC home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1984 Feb;37(2):182–187. doi: 10.1136/jcp.37.2.182

Assessment of platelet function in patients with Raynaud's syndrome.

R A Hutton, D P Mikhailidis, R M Bernstein, J Y Jeremy, G R Hughes, P Dandona
PMCID: PMC498675  PMID: 6229551

Abstract

Platelet function was studied in 11 patients with Raynaud's syndrome and 11 healthy controls. Platelets obtained from patients with Raynaud's syndrome were significantly more responsive to adrenaline, produced more thromboxane A2, and were resistant to prostaglandin inhibitors (prostacyclin and prostaglandin E1) of platelet aggregation. Platelets from control subjects and patients with Raynaud's syndrome were more resistant to prostaglandin inhibitors when reactions were carried out at 27 degrees C rather than at 37 degrees C. Patients with Raynaud's syndrome also had significantly increased plasma concentrations of beta-thromboglobulin, fibrinogen, and circulating platelet aggregates. In an attempt to elicit local platelet responses, the forearms of control subjects and patients with Raynaud's syndrome were cooled in water tanks and platelet function tests performed before and after cooling. No significant difference in the results was observed. The potential role of platelets in the pathogenesis of Raynaud's syndrome is discussed.

Full text

PDF
186

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Belch J. J., Newman P., Drury J. K., McKenzie F., Capell H., Leiberman P., Forbes C. D., Prentice C. R. Intermittent epoprostenol (prostacyclin) infusion in patients with Raynaud's syndrome. A double-blind controlled trial. Lancet. 1983 Feb 12;1(8320):313–315. doi: 10.1016/s0140-6736(83)91624-0. [DOI] [PubMed] [Google Scholar]
  2. Best L. C., Holland T. K., Jones P. B., Russell R. G. The interrelationship between thromboxane biosynthesis, aggregation and 5-hydroxytryptamine secretion in human platelets in vitro. Thromb Haemost. 1980 Feb 29;43(1):38–40. [PubMed] [Google Scholar]
  3. Blunt R. J., George A. J., Hurlow R. A., Strachan C. J., Stuart J. Hyperviscosity and thrombotic changes in idiopathic and secondary Raynaud's syndrome. Br J Haematol. 1980 Aug;45(4):651–658. doi: 10.1111/j.1365-2141.1980.tb07188.x. [DOI] [PubMed] [Google Scholar]
  4. Dowd P. M., Kovacs I. B., Bland C. J., Kirby J. D. Effect of prostaglandins I2 and E1 on red cell deformability in patients with Raynaud's phenomenon and systemic sclerosis. Br Med J (Clin Res Ed) 1981 Aug 1;283(6287):350–350. doi: 10.1136/bmj.283.6287.350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Downey J. A., Frewin D. B. The effect of cold on blood flow in the hand of patients with Raynaud's phenomenon. Clin Sci. 1973 Mar;44(3):279–289. doi: 10.1042/cs0440279. [DOI] [PubMed] [Google Scholar]
  6. Holmsen H., Holmsen I., Bernhardsen A. Microdetermination of adenosine diphosphate and adenosine triphosphate in plasma with firefly luciferase system. Anal Biochem. 1966 Dec;17(3):456–473. doi: 10.1016/0003-2697(66)90181-3. [DOI] [PubMed] [Google Scholar]
  7. Holmsen I., Holmsen H. Partial purification and characterization of an ADP phosphohydrolase from human plasma. Thromb Diath Haemorrh. 1971 Aug 31;26(1):177–191. [PubMed] [Google Scholar]
  8. INGRAM G. I. A suggested schedule for the rapid investigation of acute haemostatic failure. J Clin Pathol. 1961 Jul;14:356–360. doi: 10.1136/jcp.14.4.356. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Jahnsen T., Nielsen S. L., Skovborg F. Blood viscosity and local response to cold in primary Raynaud's phenomenon. Lancet. 1977 Nov 12;2(8046):1001–1002. doi: 10.1016/s0140-6736(77)92895-1. [DOI] [PubMed] [Google Scholar]
  10. Jarrett P. E., Morland M., Browse N. L. Treatment of Raynaud's phenomenon by fibrinolytic enhancement. Br Med J. 1978 Aug 19;2(6136):523–525. doi: 10.1136/bmj.2.6136.523. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kattlove H. E., Alexander B. The effect of cold on platelets. I. Cold-induced platelet aggregation. Blood. 1971 Jul;38(1):39–48. [PubMed] [Google Scholar]
  12. Martin M. F., Tooke J. E. Effects of prostaglandin E1 on microvascular haemodynamics in progressive systemic sclerosis. Br Med J (Clin Res Ed) 1982 Dec 11;285(6356):1688–1690. doi: 10.1136/bmj.285.6356.1688. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Mikhailidis D. P., Hutton R. A., Jeremy J. Y., Dandona P. Hypothermia and pancreatitis. J Clin Pathol. 1983 Apr;36(4):483–484. doi: 10.1136/jcp.36.4.483. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Moncada S., Vane J. R. Prostacyclin: homeostatic regulator or biological curiosity? Clin Sci (Lond) 1981 Oct;61(4):369–372. doi: 10.1042/cs0610369. [DOI] [PubMed] [Google Scholar]
  15. Needleman P., Minkes M., Raz A. Thromboxanes: selective biosynthesis and distinct biological properties. Science. 1976 Jul 9;193(4248):163–165. doi: 10.1126/science.945611. [DOI] [PubMed] [Google Scholar]
  16. Neri Serheri G. G., Abbate R., Gensini G. F., Galanti G., Paoli G., Laureano R. Platelet aggregation and thromboxane A2 production after adrenergic stimulation in young healthy humans. Haemostasis. 1982;11(1):40–48. doi: 10.1159/000214639. [DOI] [PubMed] [Google Scholar]
  17. Pardy B. J., Hoare M. C., Eastcott H. H., Miles C. C., Needham T. N., Harbourne T., Ellis B. W. Prostaglandin E1 in severe Raynaud's phenomenon. Surgery. 1982 Dec;92(6):953–965. [PubMed] [Google Scholar]
  18. Rodnan G. P., Myerowitz R. L., Justh G. O. Morphologic changes in the digital arteries of patients with progressive systemic sclerosis (scleroderma) and Raynaud phenomenon. Medicine (Baltimore) 1980 Nov;59(6):393–408. doi: 10.1097/00005792-198011000-00001. [DOI] [PubMed] [Google Scholar]
  19. Stranden E., Roald O. K., Krohg K. Treatment of Raynaud's phenomenon with the 5-HT2-receptor antagonist ketanserin. Br Med J (Clin Res Ed) 1982 Oct 16;285(6348):1069–1071. doi: 10.1136/bmj.285.6348.1069. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Tietjen G. W., Chien S., Leroy E. C., Gavras I., Gavras H., Gump F. E. Blood viscosity, plasma proteins, and Raynaud syndrome. Arch Surg. 1975 Nov;110(11):1343–1346. doi: 10.1001/archsurg.1975.01360170083011. [DOI] [PubMed] [Google Scholar]
  21. Vanhoutte P. M., Shepherd J. T. Effect of temperature on reactivity of isolated cutaneous veins of the dog. Am J Physiol. 1970 Jan;218(1):187–190. doi: 10.1152/ajplegacy.1970.218.1.187. [DOI] [PubMed] [Google Scholar]
  22. Woodhams B. J., Kernoff P. B. The application of polyethylene glycol to radioimmunoassays used in haemostasis. Thromb Res. 1983 Feb 1;29(3):333–341. doi: 10.1016/0049-3848(83)90045-2. [DOI] [PubMed] [Google Scholar]
  23. Wu K. K., Hoak J. C. A new method for the quantitative detection of platelet aggregates in patients with arterial insufficiency. Lancet. 1974 Oct 19;2(7886):924–926. doi: 10.1016/s0140-6736(74)91131-3. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES